Radiofrequency ablation of unresectable hepatic tumors

Diagnostic and Interventional Radiology

Volumn 12, Issue 4, 2006, Pages 195-200

  Geyik, Serdar ^a   Akhan, Okan ^a   Abbasoǧlu, Osman ^a   Akinci, Devrim ^a   Şeref Özkan, Orhan ^a   Hamaloǧlu, Erhan ^a   Özmen, Mustafa ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Catheter ablation; Liver neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BURN; CANCER MORTALITY; CANCER RECURRENCE; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE COURSE; EMPYEMA; FEMALE; FOLLOW UP; GALLBLADDER CARCINOMA; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER NODULE; MALE; METASTASIS POTENTIAL; MINIMAL RESIDUAL DISEASE; OUTCOME ASSESSMENT; PATIENT SAFETY; PREOPERATIVE EVALUATION; RADIOFREQUENCY ABLATION; STROKE; SURGICAL DRAINAGE; TREATMENT OUTCOME; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; TURKEY;

EID: 33845892514     PISSN: 13053825     EISSN: 13053612     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Parkin AM, Stjernsward J, Muir CS. Estimates of the worldwide frequency of twelve major cancers. Bull Wld Hlth Org 1984; 62:163-182.
2. American Cancer Society. Cancer facts and figures 2002. Washington DC: American Cancer Society; 2002.
3. Pickren JW, Tsukada Y, Lane WW. Liver metastasis: analysis of autopsy data. In: Weiss L, Gilbert HA eds. Liver metastasis. Boston: Hall Medical Publishers, 1982; 2-19.
4. Curley SA. Radiofrequency ablation of malignant liver tumors. Oncologist 2001; 6:14-23.
5. Cha C, DeMatteo RP, Blumgart LH. Surgery and ablative therapy for hepatocellular carcinoma. J Clin Gastroenterol 2002; 35:130-137.
6. Cheng J, Glasgow RE, O Rourke RW, Swanstrom LL, Hansen PD. Laparoscopic radiofrequency ablation and hepatic artery infusion pump placement in the evolving treatment of colorectal hepatic metastases. Surg Endosc 2003; 17:61-67.
7. Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. Cancer 1992; 69:925-929.
8. Higuchi T, Kikuchi M, Okazaki M. Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases. Cancer 1994; 73:2259-2267.
9. Dalal KS, Dupuy DE, Goldberg SN. Radiofrequency ablation of hepatic tumors. Semin Interv Radiol 2003; 20:279-292.
10. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies. Ann Surg 1999; 230:1-8.
11. Pinedo HM, Van Groeningen CJ. Emerging new opportunities for patients with hepatic metastasis from colorectal cancer or primary hepatocellular cancer. Oncologist 2001; 6:12-13.
12. Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 1992; 69:925-929.
13. Lencioni R, Allgaiger HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison RF thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228:235-240
14. Bengstsson G, Carlsson G, Hafstrom L, Jonsson PE. Natural history of patients with untreated metastases from colorectal cancer. Am J Surg 1981; 141:586-589.
15. Livraghi T, Solbiati L, Meloni F, et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection. Cancer 2003; 97:3027-3035.
16. Hughes KS, Rosenstein RB, Songhorabodi S, et al. Resection of liver for colorectal carcinoma metastases: a multi-institutional study of long-term survivors. Dis Colon Rectum 1988; 31:1-4.
17. Rossi S, Fornari F, Pathies C, Buscarini L. Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver. Tumori 1990; 76:54-57.
18. McGahan JP, Browning PD, Brock JM. Hepatic ablation using radiofrequency electrocautery. Invest Radiol 1990; 25:267-270.
19. Antoch G, Kuehl H, Florian M, et al. Value of CT volume imaging for optimal placement of RFA probes in liver lesions. JVIR 2002; 13:1155-1161.
20. Goldberg SN, Charboneau JW, Dodd GD, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003; 228:335-345.
21. Morimoto M, Sugimori K, Shirato K, et al. Treatment of HCC with radiofrequency ablation: radiologic-histologic correlation during follow-up periods. Hepatology 2002; 35:1467-1475.
22. Solbiati L, Goldberg SN, Ierace T, et al. Long-term follow-up of liver metastases treated with percutaneous US-guided RF ablation using internally cooled electrodes. Radiology 1998; 209:449-454.
23. Komorizono M, Oketani M, Sako K, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 2003; 97:1253-1262.
24. Seidenfeld J, Aronson N, Korn A. Radiofrequency ablation of unresectable liver metastases. J Am Coll Surg 2002; 195:378-386.
25. Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous complications encountered in a multicenter study. Radiology 2003; 226:441-451.